News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nature Medicine Features KineMed, Inc.'s Fibrosis Research, Which Aims to Advance Therapeutics for the Underlying Cause of 45% of All Deaths



1/20/2011 8:20:21 AM

(BUSINESS WIRE)--KineMed Inc.’s (www.kinemed.com) fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES